HomeOXB • LON
Follow
Oxford BioMedica plc
Previous close
GBX 197.20
Day range
GBX 193.63 - GBX 202.50
Year range
GBX 164.29 - GBX 474.50
Market cap
200.63M GBP
Avg Volume
348.49K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | 21.53M | -32.75% |
Operating expense | 36.58M | 45.91% |
Net income | -23.98M | -88.19% |
Net profit margin | -111.37 | -179.82% |
Earnings per share | — | — |
EBITDA | -21.35M | -1,381.06% |
Effective tax rate | -0.61% | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 129.43M | 9.18% |
Total assets | 401.06M | -14.06% |
Total liabilities | 202.91M | -1.83% |
Total equity | 198.16M | — |
Shares outstanding | 96.52M | — |
Price to book | 1.11 | — |
Return on assets | -15.97% | — |
Return on capital | -20.57% | — |
Cash Flow
Net change in cash
(GBP) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -23.98M | -88.19% |
Cash from operations | -2.71M | 77.91% |
Cash from investing | 891.50K | 101.70% |
Cash from financing | -3.45M | -105.05% |
Net change in cash | -5.93M | -223.93% |
Free cash flow | -10.41M | -538.71% |
About
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange. Wikipedia
Founded
1995
Website
Employees
891